Insider Buying: INOVIQ (ASX:IIQ) Insider Acquires 85,714 Shares of Stock

INOVIQ Ltd (ASX:IIQ) insider Robert (Max) Johnston bought 85,714 shares of the business’s stock in a transaction dated Wednesday, November 5th. The shares were bought at an average price of A$0.35 per share, with a total value of A$29,999.90.

INOVIQ Price Performance

The company has a quick ratio of 9.52, a current ratio of 7.07 and a debt-to-equity ratio of 2.02. The stock has a market capitalization of $47.40 million, a P/E ratio of -6.02 and a beta of 2.04.

About INOVIQ

INOVIQ Ltd engages in the research, development, and commercialization of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET for capturing and isolating exosomes from liquid biopsy sample.